Back
Sep 30
Scientific
SS 42 - Gyn 4: GYN Clinical Trials - Challenging the paradigm in gynecologic cancers
MODERATOR(S)
Denise Fabian, MD - University of Kentucky
Kristin Bradley, MD - University of Wisconsin
Credits
AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
04:00pm - 05:00pm PT
Gyn 4: GYN Clinical Trials - Challenging the paradigm in gynecologic cancers
Speaker: Denise Fabian, MD - University of Kentucky, Lexington -
04:00pm - 05:00pm PT
Gyn 4: GYN Clinical Trials - Challenging the paradigm in gynecologic cancers
Speaker: Kristin Bradley, MD - University of Wisconsin, Madison -
04:00pm - 04:10pm PT
Survival Outcomes of Induction Immunotherapy Combined with Platinum-Based Doublet Chemotherapy Followed by Immunotherapy and Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer: A Phase II
Speaker: Yi-Di Yuan, DO - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing -
04:10pm - 04:20pm PT
Application of Polyethylene Glycol (PEG) Hydrogel in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent Radiation-Induced Rectal Injury: A Multicenter, Randomized, Parallel-Controlled
Speaker: Junfang Yan, MD - Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College., Beijing -
04:20pm - 04:30pm PT
Phase 3 Study of Pembrolizumab (Pembro) + Adjuvant Chemotherapy (CT) ± Radiotherapy (RT) for Newly Diagnosed, High-Risk Endometrial Cancer (EC): Exploratory Analysis of Disease-Specific-Free Survival
Speaker: Jyoti Mayadev, MD - University of California, San Diego Medical Center, San Diego -
04:30pm - 04:40pm PT
Nimotuzumab Plus Concurrent Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma: Updated Follow-up from the Randomized, Phase 3 CC3 Study
Speaker: Junjie Wang, MD - Peking University Third Hospital, Beijing -
04:40pm - 04:50pm PT
The Endoscopy Results of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-Induced Acute Rectal Injury: A Multi-Center,
Speaker: Jiawei Zhu, MD - Peking Union Medical College Hospital, Beijing -
04:50pm - 05:00pm PT
Discussant
Speaker: Junzo Chino, MD, FASTRO - Duke Cancer Institute, Durham